Viewing StudyNCT00095888



Ignite Creation Date: 2024-05-05 @ 11:37 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00095888
Status: TERMINATED
Last Update Posted: 2013-01-16
First Post: 2004-11-09

Brief Title: 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Stage IV Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Keywords: